Barclays PLC Omega Therapeutics, Inc. Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 13,278 shares of OMGA stock, worth $265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,278

Previous 13,278 -0.0%

Holding current value

$265

Previous $10,000 90.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$1.22 - $2.25 $218 - $402	-179 Reduced 1.33%	13,278 $16,000
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.2 $31,649 - $54,451	-17,016 Reduced 55.84%	13,457 $27,000
Q1 2024 May 15, 2024	SELL	$2.73 - $5.32 $45,045 - $87,780	-16,500 Reduced 35.13%	30,473 $111,000
Q4 2023 Feb 15, 2024	BUY	$1.35 - $3.21 $39,167 - $93,131	29,013 Added 161.54%	46,973 $142,000
Q3 2023 Nov 07, 2023	SELL	$2.15 - $5.68 $436 - $1,153	-203 Reduced 1.12%	17,960 $39,000
Q2 2023 Aug 03, 2023	SELL	$5.6 - $9.66 $19,516 - $33,665	-3,485 Reduced 16.1%	18,163 $101,000
Q1 2023 May 04, 2023	BUY	$4.81 - $10.95 $1,577 - $3,591	328 Added 1.54%	21,648 $131,000
Q4 2022 Feb 13, 2023	BUY	$4.22 - $7.05 $30,907 - $51,634	7,324 Added 52.33%	21,320 $122,000
Q3 2022 Nov 03, 2022	BUY	$3.63 - $6.65 $2,606 - $4,774	718 Added 5.41%	13,996 $76,000
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $7,471 - $26,725	-3,717 Reduced 21.87%	13,278 $50,000
Q1 2022 May 16, 2022	BUY	$6.24 - $14.04 $106,048 - $238,609	16,995 New	16,995 $106,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

1.51M

Call Options Held

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $957K
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account